Concurrent expression of f-circM9 and MLL-AF9 protein contributed to leukemia progression in in vivo and ex vivo models, and f-circM9 expression increased drug resistance of leukemic cells (Guarnerio et al., 2016). This evidence concerns the gene MLLT3 and leukemia.